Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
A model-based approach to predict individual weight loss with semaglutide in people with overweight or obesityDiabetes Obes Metab 2023 Jul 09;[EPub Ahead of Print], A Strathe, DB Horn, MS Larsen, D Rubino, R Sørrig, MTD Tran, S Wharton, RV Overgaard
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.